Drugs / EPAG-pfos
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07001397 Comparator | Jun 2025 → Mar 2026 overdue | aplastic anemia | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPAG-pfos | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07001397 ↗ |
| Route | Oral | “150mg/d orally” NCT07001397 ↗ |